Latest Breaking News On - Edna kaplan - Page 1 : vimarsana.com

Immunic to Participate in Industry and Scientific Conferences in June

/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for.

EQS-News: Immunic AG: Immunic to Participate in Industry and Scientific Conferences in June

Issuer: Immunic AG / Key word(s): Conference Immunic to Participate in Industry and Scientific Conferences in June 28.05.2024 / 12:30 CET/CEST The issuer is solely responsible

EQS-News: Immunic AG: Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update

Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update

Immunic to Participate in Investor and Scientific Conferences in May

NEW YORK, May 6, 2024 /PRNewswire/  Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and.

EQS-News: Immunic AG: Immunic to Participate in Investor and Scientific Conferences in May

EQS-News: Immunic AG: Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update

Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update

/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for.

EQS-News: Immunic AG: Immunic to Host MS R&D Day and Participate in Investor Conferences in April

Immunic to Host MS R&D Day and Participate in Investor Conferences in April

NEW YORK, April 4, 2024 /PRNewswire/  Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and.